Farmacia hospitalaria
Especialidad
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (9)
2021
-
Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study)
International Journal of Cancer, Vol. 148, Núm. 6, pp. 1360-1371
-
Occupational heat exposure and breast cancer risk in the MCC-Spain study
Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 2, pp. 364-372
-
Social mobility and healthy behaviours from a gender perspective in the Spanish multicase-control study (MCC-Spain)
PLoS ONE, Vol. 16, Núm. 5 May
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2020
-
Association between polyphenol intake and breast cancer risk by menopausal and hormone receptor status
Nutrients, Vol. 12, Núm. 4
-
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses
BMC medicine, Vol. 18, Núm. 1, pp. 229
-
Dietary and circulating fatty acids and ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition
Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 9, pp. 1739-1749
2019
-
Dietary inflammatory index, dietary non-enzymatic antioxidant capacity, and colorectal and breast cancer risk (MCC-Spain study)
Nutrients, Vol. 11, Núm. 6
-
Moderate egg consumption and all-cause and specific-cause mortality in the Spanish European Prospective into Cancer and Nutrition (EPIC-Spain) study
European Journal of Nutrition, Vol. 58, Núm. 5, pp. 2003-2010